Medical Countermeasures W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four CountriesGlobal Biodefense StaffMarch 19, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxGlobal Biodefense StaffMarch 12, 2025
Abbott Launches Laboratory-Based Antibody Blood Test with Manufacturing Scaling Targets Industry News April 15, 2020 …
Inside the Effort to Repurpose a Manufacturing Platform to Produce COVID-19 Vaccines Medical Countermeasures April 15, 2020 …
BARDA Facilitates Development of Immunotherapies for COVID-19 Patients Industry News April 14, 2020 …
BARDA and Vela Diagnostics partner to develop rapid diagnostic test for the COVID-19 Industry News April 14, 2020 …
Ridgeback Receives UK Clearance to Begin Human Testing of Antiviral for COVID-19 Industry News April 14, 2020 …
BARDA Supports DiaSorin to Develop a Fully Automated Serology Test to Detect COVID-19 Infections Industry News April 13, 2020 …
FDA Approves Ridgeback Biotherapeutics to Begin Human Testing of Potential Treatment for COVID-19 Medical Countermeasures April 7, 2020 …
INOVIO Initiates Phase 1 Clinical Trial of COVID-19 Vaccine Candidate Medical Countermeasures April 7, 2020 …
BARDA and Genentech to Accelerate Phase 3 Clinical Trial of a Novel COVID-19 Therapeutic Treatment Industry News April 6, 2020 …
Amgen and Adaptive Biotechnologies Announce Collaboration to Develop a Therapeutic to Prevent or Treat COVID-19 Medical Countermeasures April 2, 2020 …
Emergent BioSolutions Partners with BARDA to Expedite Development of Plasma-Derived Therapy for COVID-19 Medical Countermeasures April 2, 2020 …
Celularity Announces FDA Clearance of IND Application for CYNK-001 in Coronavirus, First in Cellular Therapy Medical Countermeasures April 2, 2020 …
Tests in Engineered Human Tissues Show hrsACE2 Drug Blocked Early Stages of SARS-CoV-2 Infection Medical Countermeasures April 2, 2020 …
Hydroxychloroquine and Azythromycine Combo Treatment for COVID Can Raise Risk for Dangerous Abnormal Heart Rhythms Medical Countermeasures April 2, 2020 …
JPEO-CBRND, BARDA Partner with SAb Biotherapeutics to Develop COVID-19 Therapeutic Medical Countermeasures April 1, 2020 …
Sanofi and Translate Bio Team Up to Develop Novel Coronavirus mRNA Vaccine Medical Countermeasures March 28, 2020 …
Mapping Risks to the Drug Supply Chain During COVID-19 Pandemic: Critical Shortages Likely in U.S. Medical Countermeasures March 28, 2020 …
